Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.
Your search for Warfarin returned 3 results
Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.
Findings may help with decision-making in this high-risk patient population.